Cannabis Control Division April 2025 Newsletter
On March 6, 2025, the FDA issued a warning about Pico IV Inc., an intravenous CBD supplement. The FDA stated: “’Pico IV’ product is especially concerning from a public health perspective because injectable drug products can pose risks of serious harm to …